Sample: OECD Health: Hip and Knee Patient-Reported Outcome Measures
Free preview (100 rows). Same data as
GET /api/datasets/dsd-hcqo-df-hkp/sample.
health
Preview
| action | ref_area | reference_area | freq | frequency_of_observation | measure_code | measure_name | unit_measure | unit_of_measure | age_code | age_name | sex_code | sex_name | statistical_operation_code | statistical_operation_name | income_group_code | income_group_name | health_prof | health_profession | year | time_period | value | observation_value | hspa | health_system_performance_assessment | methodology | calculation_methodology | time_range_code | time_range_name | survey_version_code | survey_version_name | decimals_code | decimals_name | obs_status | observation_status | obs_status2 | observation_status_2 | obs_status3 | observation_status_3 | unit_mult | unit_multiplier |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | DEU | Germany | A | Annual | POPREOKS | Pre-operative patient-reported outcomes among people who undergo knee replacement surgery (pre-operative Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 21.3 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | NLD | Netherlands | A | Annual | POPREEQK | Pre-operative patient-reported outcomes among people who undergo knee replacement surgery (pre-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.5 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | DEU | Germany | A | Annual | POCHGEQH | Change from pre-op to post-op patient-reported outcomes among people who undergo hip surgery (change in EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.4 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | DEU | Germany | A | Annual | POCHGEQH | Change from pre-op to post-op patient-reported outcomes among people who undergo hip surgery (change in EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.4 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CAN | Canada | A | Annual | POPSTEQK | Post-operative patient-reported outcomes among people who undergo knee replacement surgery (post-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 0.8 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | GBR | United Kingdom | A | Annual | POPREOKS | Pre-operative patient-reported outcomes among people who undergo knee replacement surgery (pre-operative Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 19.0 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | IRL | Ireland | A | Annual | POPREEQH | Pre-operative patient-reported outcomes among people who undergo hip surgery (pre-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 0.5 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | IRL | Ireland | A | Annual | POCHGOKS | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 17.3 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | DEU | Germany | A | Annual | POCHGEQK | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.3 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | NOR | Norway | A | Annual | POCHGEQK | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.2 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CHE | Switzerland | A | Annual | POPREOKS | Pre-operative patient-reported outcomes among people who undergo knee replacement surgery (pre-operative Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2021 | 22.2 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CHE | Switzerland | A | Annual | POPREOKS | Pre-operative patient-reported outcomes among people who undergo knee replacement surgery (pre-operative Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2022 | 22.1 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CHE | Switzerland | A | Annual | POPREOKS | Pre-operative patient-reported outcomes among people who undergo knee replacement surgery (pre-operative Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 20.1 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | DEU | Germany | A | Annual | POPSTEQK | Post-operative patient-reported outcomes among people who undergo knee replacement surgery (post-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.8 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | NLD | Netherlands | A | Annual | POCHGOHS | Change from pre-op to post-op patient-reported outcomes among people who undergo hip surgery (change in Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 19.5 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | IRL | Ireland | A | Annual | POPREOKS | Pre-operative patient-reported outcomes among people who undergo knee replacement surgery (pre-operative Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 23.2 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | SVN | Slovenia | A | Annual | POPSTOHS | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 41.5 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | NOR | Norway | A | Annual | POCHGEQK | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.2 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CHE | Switzerland | A | Annual | POPSTOKS | Post-operative patient-reported outcomes among people who undergo knee replacement surgery (post-operative Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2021 | 36.7 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CHE | Switzerland | A | Annual | POPSTOKS | Post-operative patient-reported outcomes among people who undergo knee replacement surgery (post-operative Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2022 | 36.1 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CHE | Switzerland | A | Annual | POPSTOKS | Post-operative patient-reported outcomes among people who undergo knee replacement surgery (post-operative Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 38.9 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | AUS | Australia | A | Annual | POPSTOHS | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2022 | 42.1 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | AUS | Australia | A | Annual | POPSTOHS | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 42.0 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | AUS | Australia | A | Annual | POPSTOHS | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 41.5 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | NOR | Norway | A | Annual | POCHGEQH | Change from pre-op to post-op patient-reported outcomes among people who undergo hip surgery (change in EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.3 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | GBR | United Kingdom | A | Annual | POCHGEQH | Change from pre-op to post-op patient-reported outcomes among people who undergo hip surgery (change in EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.6 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | NOR | Norway | A | Annual | POCHGEQH | Change from pre-op to post-op patient-reported outcomes among people who undergo hip surgery (change in EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.3 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | DEU | Germany | A | Annual | POCHGOHS | Change from pre-op to post-op patient-reported outcomes among people who undergo hip surgery (change in Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 16.6 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CAN | Canada | A | Annual | POCHGOHS | Change from pre-op to post-op patient-reported outcomes among people who undergo hip surgery (change in Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 22.9 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | DEU | Germany | A | Annual | POPSTEQH | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.8 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | DEU | Germany | A | Annual | POCHGOKS | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 14.9 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | NOR | Norway | A | Annual | POPSTEQH | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.9 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CAN | Canada | A | Annual | POCHGEQH | Change from pre-op to post-op patient-reported outcomes among people who undergo hip surgery (change in EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 0.4 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | NLD | Netherlands | A | Annual | POCHGOKS | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 14.8 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | IRL | Ireland | A | Annual | POPSTEQH | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 0.8 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CAN | Canada | A | Annual | POPSTEQH | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 0.8 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | IRL | Ireland | A | Annual | POPREOHS | Pre-operative patient-reported outcomes among people who undergo hip replacement surgery (pre-operative Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 17.8 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CAN | Canada | A | Annual | POPREEQK | Pre-operative patient-reported outcomes among people who undergo knee replacement surgery (pre-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 0.6 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | DEU | Germany | A | Annual | POCHGOHS | Change from pre-op to post-op patient-reported outcomes among people who undergo hip surgery (change in Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 17.5 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | SVN | Slovenia | A | Annual | POPSTEQH | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 0.8 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | IRL | Ireland | A | Annual | POCHGOHS | Change from pre-op to post-op patient-reported outcomes among people who undergo hip surgery (change in Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 23.1 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | NLD | Netherlands | A | Annual | POPSTOKS | Post-operative patient-reported outcomes among people who undergo knee replacement surgery (post-operative Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 40.5 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | SVN | Slovenia | A | Annual | POPREEQK | Pre-operative patient-reported outcomes among people who undergo knee replacement surgery (pre-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.7 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | DEU | Germany | A | Annual | POPSTEQK | Post-operative patient-reported outcomes among people who undergo knee replacement surgery (post-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.8 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | DEU | Germany | A | Annual | POCHGOKS | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 16.5 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | IRL | Ireland | A | Annual | POCHGOKS | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 16.3 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | FIN | Finland | A | Annual | POPREOKS | Pre-operative patient-reported outcomes among people who undergo knee replacement surgery (pre-operative Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 25.4 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CAN | Canada | A | Annual | POCHGOKS | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 17.8 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | SVN | Slovenia | A | Annual | POPREEQH | Pre-operative patient-reported outcomes among people who undergo hip surgery (pre-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.6 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | GBR | United Kingdom | A | Annual | POCHGEQK | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.2 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CAN | Canada | A | Annual | POPREOHS | Pre-operative patient-reported outcomes among people who undergo hip replacement surgery (pre-operative Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 18.7 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | SVN | Slovenia | A | Annual | POCHGOKS | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 17.2 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | DEU | Germany | A | Annual | POPREOHS | Pre-operative patient-reported outcomes among people who undergo hip replacement surgery (pre-operative Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 19.5 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CAN | Canada | A | Annual | POPREOKS | Pre-operative patient-reported outcomes among people who undergo knee replacement surgery (pre-operative Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 20.2 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | DEU | Germany | A | Annual | POCHGEQK | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.3 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | NLD | Netherlands | A | Annual | POCHGEQH | Change from pre-op to post-op patient-reported outcomes among people who undergo hip surgery (change in EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.4 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | IRL | Ireland | A | Annual | POPSTOHS | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 41.9 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | SVN | Slovenia | A | Annual | POCHGOHS | Change from pre-op to post-op patient-reported outcomes among people who undergo hip surgery (change in Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 21.1 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | SVN | Slovenia | A | Annual | POPSTEQH | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 0.8 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | SVN | Slovenia | A | Annual | POPREOHS | Pre-operative patient-reported outcomes among people who undergo hip replacement surgery (pre-operative Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 20.4 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | NOR | Norway | A | Annual | POCHGEQH | Change from pre-op to post-op patient-reported outcomes among people who undergo hip surgery (change in EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.3 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CAN | Canada | A | Annual | POPSTOHS | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 42.4 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | DEU | Germany | A | Annual | POPSTOKS | Post-operative patient-reported outcomes among people who undergo knee replacement surgery (post-operative Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 37.0 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CHE | Switzerland | A | Annual | POCHGOKS | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2021 | 14.6 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CHE | Switzerland | A | Annual | POCHGOKS | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2022 | 16.1 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CHE | Switzerland | A | Annual | POCHGOKS | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 18.1 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | IRL | Ireland | A | Annual | POCHGEQK | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 0.2 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CAN | Canada | A | Annual | POPSTOHS | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 41.9 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CAN | Canada | A | Annual | POPSTOKS | Post-operative patient-reported outcomes among people who undergo knee replacement surgery (post-operative Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 38.9 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | NLD | Netherlands | A | Annual | POPREOHS | Pre-operative patient-reported outcomes among people who undergo hip replacement surgery (pre-operative Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 22.6 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | DEU | Germany | A | Annual | POPSTEQH | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.8 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | IRL | Ireland | A | Annual | POCHGEQK | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 0.2 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | ISR | Israel | A | Annual | POPSTEQH | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.8 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | NOR | Norway | A | Annual | POPSTEQK | Post-operative patient-reported outcomes among people who undergo knee replacement surgery (post-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.9 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CAN | Canada | A | Annual | POCHGOKS | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 16.6 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | GBR | United Kingdom | A | Annual | POPSTOKS | Post-operative patient-reported outcomes among people who undergo knee replacement surgery (post-operative Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 38.0 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | NLD | Netherlands | A | Annual | POPSTEQH | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.8 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | DEU | Germany | A | Annual | POCHGOHS | Change from pre-op to post-op patient-reported outcomes among people who undergo hip surgery (change in Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 17.0 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CAN | Canada | A | Annual | POPREEQH | Pre-operative patient-reported outcomes among people who undergo hip surgery (pre-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 0.4 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CAN | Canada | A | Annual | POPSTEQK | Post-operative patient-reported outcomes among people who undergo knee replacement surgery (post-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 0.8 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | FIN | Finland | A | Annual | POCHGOHS | Change from pre-op to post-op patient-reported outcomes among people who undergo hip surgery (change in Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 21.5 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | NOR | Norway | A | Annual | POPREEQH | Pre-operative patient-reported outcomes among people who undergo hip surgery (pre-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.6 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | NLD | Netherlands | A | Annual | POCHGOKS | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 15.4 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | NOR | Norway | A | Annual | POPSTEQH | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.9 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | SVN | Slovenia | A | Annual | POCHGEQH | Change from pre-op to post-op patient-reported outcomes among people who undergo hip surgery (change in EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 0.2 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | IRL | Ireland | A | Annual | POCHGOKS | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 18.1 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | DEU | Germany | A | Annual | POPREEQH | Pre-operative patient-reported outcomes among people who undergo hip surgery (pre-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.4 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | NLD | Netherlands | A | Annual | POPSTOKS | Post-operative patient-reported outcomes among people who undergo knee replacement surgery (post-operative Oxford Knee Score) | 0_TO_48 | 0-48 scale | _T | Total | F | Female | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 38.1 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | IRL | Ireland | A | Annual | POPREOHS | Pre-operative patient-reported outcomes among people who undergo hip replacement surgery (pre-operative Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 18.7 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | GBR | United Kingdom | A | Annual | POPSTEQH | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.8 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | IRL | Ireland | A | Annual | POPREEQH | Pre-operative patient-reported outcomes among people who undergo hip surgery (pre-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 0.6 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CHE | Switzerland | A | Annual | POPSTOHS | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2021 | 41.5 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CHE | Switzerland | A | Annual | POPSTOHS | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2022 | 41.5 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CHE | Switzerland | A | Annual | POPSTOHS | Post-operative patient-reported outcomes among people who undergo hip surgery (post-operative Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | M | Male | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 41.6 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | AUS | Australia | A | Annual | POPREOHS | Pre-operative patient-reported outcomes among people who undergo hip replacement surgery (pre-operative Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2022 | 21.7 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | AUS | Australia | A | Annual | POPREOHS | Pre-operative patient-reported outcomes among people who undergo hip replacement surgery (pre-operative Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 21.7 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | AUS | Australia | A | Annual | POPREOHS | Pre-operative patient-reported outcomes among people who undergo hip replacement surgery (pre-operative Oxford Hip Score) | 0_TO_48 | 0-48 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 21.4 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | DEU | Germany | A | Annual | POPREEQH | Pre-operative patient-reported outcomes among people who undergo hip surgery (pre-operative EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.4 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | ISR | Israel | A | Annual | POCHGEQK | Change from pre-op to post-op patient-reported outcomes among people who undergo knee replacement surgery (change in EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2023 | 0.1 | CRUDE | Crude rate | 1 | One | ||||||||||||||||
| I | CAN | Canada | A | Annual | POCHGEQH | Change from pre-op to post-op patient-reported outcomes among people who undergo hip surgery (change in EQ-5D-5L score) | 0_TO_1 | 0-1 scale | _T | Total | _T | Total | OBS | Observed | _Z | Not applicable | _Z | Not applicable | 2024 | 0.4 | CRUDE | Crude rate | 1 | One |